Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways-Reference-Cited by-同舟云学术

Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways

Published:2016-06 Issue: Volume:95 Page:278-292
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Zhang Ying,Zhou Hao,Wu Wenbo,Shi Chen,Hu Shunying,Yin Tong,Ma Qiang,Han Tianwen,Zhang Yingqian,Tian Feng,Chen Yundai

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference59 articles.

1. Guidelines E.S.C.C.F.P. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology;Van de Werf;Eur. Heart J.,2008

2. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion;Reffelmann;Basic Res. Cardiol.,2006

3. No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction;Abbate;Eur. Heart J.,2008

4. Coronary no reflow;Schwartz;J. Mol. Cell. Cardiol.,2012

5. Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection;Tuuminen;Circulation,2011

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury;European Journal of Pharmacology;2024-08

2. Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway;In Vitro Cellular & Developmental Biology - Animal;2024-07-22

3. The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease;Pharmacological Reports;2024-06-19

4. The Association between GLP-1 Receptor-Based Agonists and the Incidence of Asthma in Patients with Type 2 Diabetes and/or Obesity: A Meta-Analysis* *;BIOMED ENVIRON SCI;2024

5. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30